Shiliang Li, Ph.D. - Publications

Affiliations: 
2011 Graduate School - New Brunswick Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Finance

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Xiong R, Zhang L, Li S, Sun Y, Ding M, Wang Y, Zhao Y, Wu Y, Shang W, Jiang X, Shan J, Shen Z, Tong Y, Xu L, Chen Y, et al. Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & Cell. PMID 33165830 DOI: 10.1007/s13238-020-00801-y  0.48
2020 Zeng F, Li S, Yang G, Luo Y, Qi T, Liang Y, Yang T, Zhang L, Wang R, Zhu L, Li H, Xu X. Design, synthesis, molecular modeling, and biological evaluation of acrylamide derivatives as potent inhibitors of human dihydroorotate dehydrogenase for the treatment of rheumatoid arthritis. Acta Pharmaceutica Sinica. B. PMID 33078092 DOI: 10.1016/j.apsb.2020.10.008  0.48
2020 Xiong R, Zhang L, Li S, Sun Y, Ding M, Wang Y, Zhao Y, Wu Y, Shang W, Jiang X, Shan J, Shen Z, Tong Y, Xu L, Chen Y, et al. Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & Cell. PMID 33029721 DOI: 10.1007/s13238-020-00792-w  0.48
2020 Xiong R, Zhang L, Li S, Sun Y, Ding M, Wang Y, Zhao Y, Wu Y, Shang W, Jiang X, Shan J, Shen Z, Tong Y, Xu L, Chen Y, et al. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2. Protein & Cell. PMID 32754890 DOI: 10.1007/s13238-020-00768-w  0.48
2020 Zhu L, Shan L, Zhu J, Li L, Li S, Wang L, Wang J, Zhang S, Zhou H, Zhang W, Li H. Discovery of a natural fluorescent probe targeting the Plasmodium falciparum cysteine protease falcipain-2. Science China. Life Sciences. PMID 32048162 DOI: 10.1007/s11427-019-1581-2  0.48
2019 Wang D, Liu W, Shen Z, Jiang L, Wang J, Li S, Li H. Deep Learning Based Drug Metabolites Prediction. Frontiers in Pharmacology. 10: 1586. PMID 32082146 DOI: 10.3389/fphar.2019.01586  0.48
2019 Zeng F, Quan L, Yang G, Qi T, Zhang L, Li S, Li H, Zhu L, Xu X. Structural Optimization and Structure-Activity Relationship of 4-Thiazolidinone Derivatives as Novel Inhibitors of Human Dihydroorotate Dehydrogenase. Molecules (Basel, Switzerland). 24. PMID 31370178 DOI: 10.3390/molecules24152780  0.48
2019 Li Q, Zhang T, Li S, Tong L, Li J, Su Z, Feng F, Sun D, Tong Y, Wang X, Zhao Z, Zhu L, Ding J, Li H, Xie H, et al. Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR. Acs Medicinal Chemistry Letters. 10: 869-873. PMID 31223440 DOI: 10.1021/acsmedchemlett.8b00564  0.48
2019 Li S, Qin C, Cui S, Xu H, Wu F, Wang J, Su M, Fang X, Li D, Jiao Q, Zhang M, Xia C, Zhu L, Wang R, Li J, et al. Correction to Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. PMID 30995042 DOI: 10.1021/acs.jmedchem.9b00559  0.48
2019 Li S, Qin C, Cui S, Xu H, Wu F, Wang J, Su M, Fang X, Li D, Jiao Q, Zhang M, Xia C, Zhu L, Wang R, Li J, et al. Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. PMID 30694668 DOI: 10.1021/acs.jmedchem.8b01491  0.48
2018 He G, Gong B, Li J, Song Y, Li S, Lu X. An Improved Receptor-Based Pharmacophore Generation Algorithm Guided by Atomic Chemical Characteristics and Hybridization Types. Frontiers in Pharmacology. 9: 1463. PMID 30618755 DOI: 10.3389/fphar.2018.01463  0.48
2018 Xiao W, Wang D, Shen Z, Li S, Li H. Multi-Body Interactions in Molecular Docking Program Devised with Key Water Molecules in Protein Binding Sites. Molecules (Basel, Switzerland). 23. PMID 30208655 DOI: 10.3390/molecules23092321  0.48
2018 Diao Y, Jiang J, Zhang S, Li S, Shan L, Huang J, Zhang W, Li H. Discovery of Natural Products as Novel and Potent FXR Antagonists by Virtual Screening. Frontiers in Chemistry. 6: 140. PMID 29761098 DOI: 10.3389/fchem.2018.00140  0.48
2018 Zheng S, Zhou Y, Fleming J, Zhou Y, Zhang M, Li S, Li H, Sun B, Liu W, Bi L. Structural and genetic analysis of START superfamily protein MSMEG_0129 from Mycobacterium smegmatis. Febs Letters. PMID 29512898 DOI: 10.1002/1873-3468.13024  0.48
2017 Zeng F, Qi T, Li C, Li T, Li H, Li S, Zhu L, Xu X. Synthesis, structure-activity relationship and binding mode analysis of 4-thiazolidinone derivatives as novel inhibitors of human dihydroorotate dehydrogenase. Medchemcomm. 8: 1297-1302. PMID 30108840 DOI: 10.1039/c7md00081b  0.48
2017 Hu X, Wang D, Tong Y, Tong L, Wang X, Zhu L, Xie H, Li S, Yang Y, Xu Y. Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors. Frontiers in Chemistry. 5: 101. PMID 29250520 DOI: 10.3389/fchem.2017.00101  0.44
2017 Li E, Wang Y, Yu W, Lv Z, Peng Y, Liu B, Li S, Ho W, Wang Q, Li H, Chang J. Synthesis and biological evaluation of a novel β-D-2'-deoxy-2'-α-fluoro-2'-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection. European Journal of Medicinal Chemistry. 143: 107-113. PMID 29172078 DOI: 10.1016/j.ejmech.2017.11.024  0.48
2017 Xiao W, He Z, Sun M, Li S, Li H. Statistical Analysis, Investigation and Prediction of the Water Positions in the Binding Sites of Proteins. Journal of Chemical Information and Modeling. PMID 28605584 DOI: 10.1021/acs.jcim.6b00620  0.48
2017 Wang X, Shen Y, Wang S, Li S, Zhang W, Liu X, Lai L, Pei J, Li H. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research. PMID 28472422 DOI: 10.1093/nar/gkx374  0.48
2016 Zhou W, Li S, Lu W, Yuan J, Xu Y, Li H, Huang J, Zhao Z. Isoindole-1,3-dione derivatives as RSK2 inhibitors: Synthesis, molecular docking simulation and SAR analysis Medchemcomm. 7: 292-296. DOI: 10.1039/c5md00469a  0.36
2015 Li S, Song Y, Liu X, Li H. A Rapid Python-Based Methodology for Target-Focused Combinatorial Library Design. Combinatorial Chemistry & High Throughput Screening. PMID 26522993  0.48
2015 Li S, Luan G, Ren X, Song W, Xu L, Xu M, Zhu J, Dong D, Diao Y, Liu X, Zhu L, Wang R, Zhao Z, Xu Y, Li H. Rational Design of Benzylidenehydrazinyl-Substituted Thiazole Derivatives as Potent Inhibitors of Human Dihydroorotate Dehydrogenase with in Vivo Anti-arthritic Activity. Scientific Reports. 5: 14836. PMID 26443076 DOI: 10.1038/srep14836  0.36
2015 Zhu J, Han L, Diao Y, Ren X, Xu M, Xu L, Li S, Li Q, Dong D, Huang J, Liu X, Zhao Z, Wang R, Zhu L, Xu Y, et al. Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase. Journal of Medicinal Chemistry. 58: 1123-39. PMID 25580811 DOI: 10.1021/jm501127s  0.44
2014 Zhang S, Shan L, Li Q, Wang X, Li S, Zhang Y, Fu J, Liu X, Li H, Zhang W. Systematic Analysis of the Multiple Bioactivities of Green Tea through a Network Pharmacology Approach. Evidence-Based Complementary and Alternative Medicine : Ecam. 2014: 512081. PMID 25525446 DOI: 10.1155/2014/512081  0.36
2014 Wang X, Chen H, Yang F, Gong J, Li S, Pei J, Liu X, Jiang H, Lai L, Li H. iDrug: a web-accessible and interactive drug discovery and design platform. Journal of Cheminformatics. 6: 28. PMID 24955134 DOI: 10.1186/1758-2946-6-28  0.48
2013 Xu T, Zhang L, Xu S, Yang CY, Luo J, Ding F, Lu X, Liu Y, Tu Z, Li S, Pei D, Cai Q, Li H, Ren X, Wang S, et al. Pyrimido[4,5-d]pyrimidin-4(1H)-one derivatives as selective inhibitors of EGFR threonine790 to methionine790 (T790M) mutants. Angewandte Chemie (International Ed. in English). 52: 8387-90. PMID 23804305 DOI: 10.1002/anie.201302313  0.36
2011 Li S, Zhou Y, Lu W, Zhong Y, Song W, Liu K, Huang J, Zhao Z, Xu Y, Liu X, Li H. Identification of inhibitors against p90 ribosomal S6 kinase 2 (RSK2) through structure-based virtual screening with the inhibitor-constrained refined homology model. Journal of Chemical Information and Modeling. 51: 2939-47. PMID 21995341 DOI: 10.1021/ci2002445  0.48
Show low-probability matches.